| In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies M McDermott, AJ Eustace, S Busschots, L Breen, J Crown, M Clynes, ... Frontiers in oncology 4, 40, 2014 | 330 | 2014 |
| Understanding cisplatin resistance using cellular models B Stordal, M Davey IUBMB life 59 (11), 696-699, 2007 | 251 | 2007 |
| Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells K Egan, D Crowley, P Smyth, S O'Toole, C Spillane, C Martin, ... PloS one 6 (10), e26125, 2011 | 216 | 2011 |
| Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review B Stordal, N Pavlakis, R Davey Cancer treatment reviews 33 (4), 347-357, 2007 | 206 | 2007 |
| A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship B Stordal, N Pavlakis, R Davey Cancer treatment reviews 33 (8), 688-703, 2007 | 167 | 2007 |
| BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation B Stordal, K Timms, A Farrelly, D Gallagher, S Busschots, M Renaud, ... Molecular oncology 7 (3), 567-579, 2013 | 151 | 2013 |
| Resistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoprotein B Stordal, M Hamon, V McEneaney, S Roche, JP Gillet, JJ O’Leary, ... PloS one 7 (7), e40717, 2012 | 102 | 2012 |
| PARP Inhibitors as P-glyoprotein Substrates D Lawlor, P Martin, S Busschots, J Thery, JJ O’leary, BT Hennessy, ... Journal of pharmaceutical sciences 103 (6), 1913-1920, 2014 | 87 | 2014 |
| Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review M Murphy, B Stordal Drug Resistance Updates 14 (3), 177-190, 2011 | 77 | 2011 |
| A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1 B Stordal, R Davey Current cancer drug targets 9 (3), 354-365, 2009 | 76 | 2009 |
| Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer LM McEvoy, SA O’Toole, CD Spillane, CM Martin, MF Gallagher, ... BMC cancer 15, 1-13, 2015 | 62 | 2015 |
| OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets SF Madden, C Clarke, B Stordal, MS Carey, R Broaddus, WM Gallagher, ... Molecular cancer 13, 1-11, 2014 | 55 | 2014 |
| The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer CJ d'Adhemar, CD Spillane, MF Gallagher, M Bates, KM Costello, ... PLoS One 9 (6), e100816, 2014 | 54 | 2014 |
| Non-invasive and non-destructive measurements of confluence in cultured adherent cell lines S Busschots, S O’Toole, JJ O’Leary, B Stordal MethodsX 2, 8-13, 2015 | 45 | 2015 |
| Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells BK Stordal, MW Davey, RA Davey Cancer chemotherapy and pharmacology 58, 256-265, 2006 | 38 | 2006 |
| BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis RD Kalachand, B Stordal, S Madden, B Chandler, J Cunningham, ... JNCI: Journal of the National Cancer Institute 112 (12), 1190-1203, 2020 | 37 | 2020 |
| Breastfeeding reduces the risk of breast cancer: A call for action in high‐income countries with low rates of breastfeeding B Stordal Cancer Medicine 12 (4), 4616-4625, 2023 | 29 | 2023 |
| Carboplatin and taxol resistance develops more rapidly in functional BRCA1 compared to dysfunctional BRCA1 ovarian cancer cells S Busschots, S O’Toole, JJ O’Leary, B Stordal Experimental cell research 336 (1), 1-14, 2015 | 26 | 2015 |
| Collateral sensitivity to cisplatin in KB-8-5-11 drug-resistant cancer cells B Doherty, D Lawlor, JP Gillet, M Gottesman, JJ O'LEARY, B Stordal Anticancer research 34 (1), 503-507, 2014 | 20 | 2014 |
| CD10−/ALDH− cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy B Ffrench, C Gasch, K Hokamp, C Spillane, G Blackshields, TM Mahgoub, ... Cell Death & Disease 8 (10), e3128-e3128, 2017 | 16 | 2017 |
O SheilsTTMI, Trinity College DublinGeverifieerd e-mailadres voor tcd.ie
